Bayer AG engages in the business of life science fields of healthcare and nutrition. The company is headquartered in Leverkusen, Nordrhein-Westfalen and currently employs 88,078 full-time employees. The firm's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on development, production and marketing of products in seeds and plant traits, crop protection, digital solutions and customer services to promote sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
Revenue
45,242
13,405
11,438
9,660
10,739
13,738
Revenue Growth (YoY)
-3%
-2%
-2%
-3%
-4%
0%
Cost of Revenue
18,404
5,232
4,501
4,307
4,364
5,625
Gross Profit
26,838
8,173
6,937
5,353
6,375
8,113
Selling, General & Admin
14,698
3,696
4,052
3,405
3,545
3,707
Research & Development
5,730
1,419
1,405
1,498
1,408
1,458
Operating Expenses
26,711
4,645
9,808
5,896
6,362
5,789
Other Non Operating Income (Expenses)
--
--
--
--
--
--
Pretax Income
-1,970
2,989
-3,372
-1,161
-426
1,830
Income Tax Expense
162
222
378
-202
-236
526
Net Income
-2,156
2,763
-3,757
-963
-199
1,299
Net Income Growth
-34%
112.99%
1,021%
-77%
484.99%
-35%
Shares Outstanding (Diluted)
982.42
982.42
982.42
982.42
982.42
982.42
Shares Change (YoY)
0%
0%
0%
0%
0%
0%
EPS (Diluted)
-2.19
2.81
-3.82
-0.98
-0.2
1.32
EPS Growth
-34%
112.99%
1,021%
-77%
486%
-35%
Free Cash Flow
2,623
-2,218
3,399
849
593
-1,403
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
59.32%
60.96%
60.64%
55.41%
59.36%
59.05%
Operating Margin
0.28%
26.31%
-25.1%
-5.62%
0.12%
16.91%
Profit Margin
-4.76%
20.61%
-32.84%
-9.96%
-1.85%
9.45%
Free Cash Flow Margin
5.79%
-16.54%
29.71%
8.78%
5.52%
-10.21%
EBITDA
2,992
4,782
-2,537
462
285
3,498
EBITDA Margin
6.61%
35.67%
-22.18%
4.78%
2.65%
25.46%
D&A For EBITDA
2,865
1,254
334
1,005
272
1,174
EBIT
127
3,528
-2,871
-543
13
2,324
EBIT Margin
0.28%
26.31%
-25.1%
-5.62%
0.12%
16.91%
Effective Tax Rate
-8.22%
7.42%
-11.2%
17.39%
55.39%
28.74%
Follow-Up Questions
What are Bayer Aktiengesellschaft's key financial statements?
According to the latest financial statement (Form-10K), Bayer Aktiengesellschaft has a total asset of $0, Net loss of $0
What are the key financial ratios for BAYRY?
Bayer Aktiengesellschaft's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Bayer Aktiengesellschaft's revenue broken down by segment or geography?
Bayer Aktiengesellschaft largest revenue segment is Other, at a revenue of 2,713,000,000 in the most earnings release.For geography, Europe/Middle East/Africa is the primary market for Bayer Aktiengesellschaft, at a revenue of 13,501,000,000.
Is Bayer Aktiengesellschaft profitable?
no, according to the latest financial statements, Bayer Aktiengesellschaft has a net loss of $0
Does Bayer Aktiengesellschaft have any liabilities?
no, Bayer Aktiengesellschaft has liability of 0
How many outstanding shares for Bayer Aktiengesellschaft?
Bayer Aktiengesellschaft has a total outstanding shares of 0